[To cast out devils by Beelzebub?]

[Article in German]

Affiliations

Comment

[Article in German]

S Müller-Lissner. Z Gastroenterol. 2012 Jul.

. 2012 Jul;50(7):702-3.

doi: 10.1055/s-0032-1312906. Epub 2012 Jul 3.

¹ Abteilung für Innere Medizin, Park-Klinik Weißensee, Schönstr. 80, 13086 Berlin. mueli@park-klinik.com

No abstract available

Comment on

Randomised clinical trial: The ileal bile acid transporter inhibitor A3309 vs. placebo in patients with chronic idiopathic constipation--a double-blind study.
Simrén M, Bajor A, Gillberg PG, Rudling M, Abrahamsson H. Simrén M, et al. Aliment Pharmacol Ther. 2011 Jul;34(1):41-50. doi: 10.1111/j.1365-2036.2011.04675.x. Epub 2011 May 5. Aliment Pharmacol Ther. 2011. PMID: 21545606 Clinical Trial.
A randomized placebo-controlled phase IIb trial of a3309, a bile acid transporter inhibitor, for chronic idiopathic constipation.
Chey WD, Camilleri M, Chang L, Rikner L, Graffner H. Chey WD, et al. Am J Gastroenterol. 2011 Oct;106(10):1803-12. doi: 10.1038/ajg.2011.162. Epub 2011 May 24. Am J Gastroenterol. 2011. PMID: 21606974 Free PMC article. Clinical Trial.
Effects of A3309, an ileal bile acid transporter inhibitor, on colonic transit and symptoms in females with functional constipation.
Wong BS, Camilleri M, McKinzie S, Burton D, Graffner H, Zinsmeister AR. Wong BS, et al. Am J Gastroenterol. 2011 Dec;106(12):2154-64. doi: 10.1038/ajg.2011.285. Epub 2011 Aug 30. Am J Gastroenterol. 2011. PMID: 21876564 Clinical Trial.